Health care cost trajectories among patients with cancer and cardiometabolic comorbidities over a decade including the pandemic period
Health care costs for patients with cancer and preexisting cardiometabolic comorbidities have increased significantly since 2012, with a temporary decline after 2019, potentially due to the COVID-19 pandemic. Patients with cancer who had cardiometabolic comorbidities had significantly higher costs than those without these conditions.
Authors
- Boon Peng Ng (ORCID: https://orcid.org/0000-0001-6070-661X)
- Ji Haeng Heo (ORCID: https://orcid.org/0000-0001-6196-9366)
- Liwei Wu (ORCID: https://orcid.org/0000-0002-3150-2260)
- Chanhyun Park
- Arianna Fa
Institutions
- University of Central Florida (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2026-03-26
- DOI
- https://doi.org/10.18553/jmcp.2026.32.4.445
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00